We are live on ! Find out more
OPRX icon

OptimizeRx
OPRX

Fund managers haven’t disclosed any holdings of OPRX yet.

OPRX Hedge Fund Activity: Q1 2026 in Review

128 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q1 2026, worth a combined $85.8M — down 48% from $164M a quarter earlier.

Fund positioning in OPRX was balanced in Q1 2026: 29 funds opened new positions, 29 closed out, 49 added to existing stakes and 28 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $2.15M. The largest seller was Next Century Growth Investors, exiting entirely with an estimated $6.2M sold.

  • 128 institutional investors held OptimizeRx (OPRX) as of Q1 2026, down from 129 in Q4 2025.
  • Funds reported $85.8M of OptimizeRx stock for Q1 2026, down 48% quarter-over-quarter.
  • 29 funds opened new OptimizeRx positions in Q1 2026 and 29 closed out, a net change of 0 holders.
  • The largest OptimizeRx buyer in Q1 2026 was Goldman Sachs, an estimated $2.15M added.
  • The largest OptimizeRx seller in Q1 2026 was Next Century Growth Investors, an estimated $6.2M sold.

Based on aggregated 13F filings for Q1 2026.